When should I start an insulin drip and how should I titrate it in a patient with hyperglycemia, particularly those with a history of diabetes complications?

When to Start an Insulin Drip and How to Titrate

Indications for Insulin Infusion

Start continuous intravenous insulin infusion when blood glucose persistently exceeds 180 mg/dL (checked on two occasions) in critically ill patients. 1

• In ICU settings, insulin therapy should be initiated at a threshold ≥180 mg/dL for most critically ill patients 1
• The Society of Critical Care Medicine and Society of Thoracic Surgeons recommend triggering insulin therapy when glucose >180 mg/dL 1
• IV insulin is the preferred method in critically ill patients due to its short half-life (<15 minutes), allowing rapid dose adjustments with unpredicted changes in nutrition or clinical status 1
• Subcutaneous insulin should be avoided in critically ill patients, particularly during hypotension or shock 1

Target Glucose Range

Once insulin infusion is started, target a glucose range of 140-180 mg/dL for the majority of critically ill patients. 1

• This target applies to both ICU and non-ICU hospitalized patients requiring IV insulin 1
• More stringent goals of 110-140 mg/dL may be appropriate for select patients (e.g., cardiac surgery patients, acute ischemic cardiac or neurological events) if achievable without significant hypoglycemia 1
• The NICE-SUGAR trial demonstrated that intensive glycemic control (80-110 mg/dL) resulted in higher mortality compared to moderate targets (140-180 mg/dL), with 10-15 fold greater rates of hypoglycemia 1
• Glucose concentrations between 180-250 mg/dL may be acceptable in patients with severe comorbidities where frequent monitoring is not feasible 1

Practical Titration Protocol

Use validated computerized or written protocols that allow predefined adjustments based on glycemic fluctuations. 1

Initial Insulin Infusion Rate:

• Start at 0.5 units/hour for most patients 2
• Adjust the infusion rate to maintain blood glucose near normoglycemia (100-160 mg/dL) 2
• In the FDA-approved protocol, patients achieved near normoglycemia in an average of 161 minutes 2

Monitoring Requirements:

• Check blood glucose every 1-2 hours initially until stable within target range 3, 4
• Once stable, glucose monitoring can be performed every 2-4 hours 3
• Point-of-care glucose testing should be performed before meals and at bedtime for patients eating regular meals 1
• For patients not eating, glucose monitoring is advised every 4-6 hours 1

Dose Adjustment Algorithm:

• Most continuous insulin infusion protocols lower blood glucose to target range within 4-8 hours 1
• Computer-based algorithms have been associated with lower rates of hypoglycemia, reduced glycemic variability, and higher percentage of glucose readings within target range 1
• Titrate insulin infusion rate based on current glucose level and rate of change 1
• If hypoglycemia occurs, reduce the infusion rate by 10-20% immediately 1

Critical Pitfalls to Avoid

Never target glucose levels of 80-110 mg/dL in critically ill patients outside of highly selected populations, as this significantly increases mortality risk. 1

• The Van den Berghe study showing benefit of tight control (80-110 mg/dL) was not replicated in the larger NICE-SUGAR trial 1
• Hypoglycemia (<54 mg/dL) is associated with worse outcomes and must be scrupulously avoided 1
• Do not use sliding scale insulin as monotherapy in hospitalized patients—it is ineffective and leads to dangerous glucose fluctuations 1, 3, 4
• Avoid relying solely on correction insulin without a scheduled basal-bolus regimen once patients transition off IV insulin 3, 4

Transition from IV to Subcutaneous Insulin

When transitioning from IV to subcutaneous insulin, calculate total subcutaneous dose as half of the IV insulin infused over 24 hours. 5

• Give 50% of the calculated total daily dose as basal insulin once in the evening 5
• Divide the remaining 50% by 3 for rapid-acting analogue before each meal 5
• Administer the first subcutaneous dose 1-2 hours before discontinuing the IV infusion to prevent rebound hyperglycemia 3

Special Populations

For elderly patients (>65 years), those with renal failure, or poor oral intake, use lower insulin doses (0.1-0.25 units/kg/day) to prevent hypoglycemia. 1, 5

• Patients on high-dose home insulin (≥0.6 units/kg/day) should have their total daily dose reduced by 20% upon hospitalization 5
• In patients with CKD Stage 5 and type 2 diabetes, reduce total daily insulin dose by 50% 5
• For patients on glucocorticoids, insulin requirements may increase by 40-60% or more, requiring more aggressive titration 6